BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 12915191)

  • 1. Improved image contrast with mangafodipir trisodium (MnDPDP) during MR-guided percutaneous cryosurgery of the liver.
    Traoré AS; Godbout MJ; Serre D; Younan R; Dionne G; Dufour M; Morin J; Moisan C
    Magn Reson Imaging; 2003 Jul; 21(6):609-15. PubMed ID: 12915191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mangafodipir trisodium (MnDPDP)-enhanced magnetic resonance imaging of the liver and pancreas.
    Wang C
    Acta Radiol Suppl; 1998; 415():1-31. PubMed ID: 9571956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining intrahepatic biliary anatomy in living liver transplant donor candidates at mangafodipir trisodium-enhanced MR cholangiography versus conventional T2-weighted MR cholangiography.
    Lee VS; Krinsky GA; Nazzaro CA; Chang JS; Babb JS; Lin JC; Morgan GR; Teperman LW
    Radiology; 2004 Dec; 233(3):659-66. PubMed ID: 15516606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of focal liver lesions: use of mangafodipir trisodium (MnDPDP)-enhanced MR images.
    Karabacakoğlu A; Adigüzel Y; Karaköse S; Kayaçetin E; Haykir R
    Turk J Gastroenterol; 2006 Sep; 17(3):164-71. PubMed ID: 16941248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mangafodipir trisodium-enhanced magnetic resonance cholangiography for detection of bile leaks].
    Assaban M; Aubé C; Lebigot J; Ridereau-Zins C; Hamy A; Caron C
    J Radiol; 2006 Jan; 87(1):41-7. PubMed ID: 16415779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of hepatocellular tumors: value of mangafodipir-enhanced magnetic resonance imaging.
    Scharitzer M; Schima W; Schober E; Reimer P; Helmberger TK; Holzknecht N; Stadler A; Ba-Ssalamah A; Weber M; Wrba F
    J Comput Assist Tomogr; 2005; 29(2):181-90. PubMed ID: 15772534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of the hepatobiliary contrast agent mangafodipir trisodium (MN-DPDP) on the imaging properties of abdominal organs.
    Jung G; Heindel W; Krahe T; Kugel H; Walter C; Fischbach R; Klaus H; Lackner K
    Magn Reson Imaging; 1998 Oct; 16(8):925-31. PubMed ID: 9814775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preoperative detection of hepatocellular carcinoma: ferumoxides-enhanced versus mangafodipir trisodium-enhanced MR imaging.
    Kim SK; Kim SH; Lee WJ; Kim H; Seo JW; Choi D; Lim HK; Lee SJ; Lim JH
    AJR Am J Roentgenol; 2002 Sep; 179(3):741-50. PubMed ID: 12185056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET.
    Sahani DV; Kalva SP; Fischman AJ; Kadavigere R; Blake M; Hahn PF; Saini S
    AJR Am J Roentgenol; 2005 Jul; 185(1):239-46. PubMed ID: 15972430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enhancement and pulse sequence analysis using low-dose mangafodipir trisodium.
    Mayo-Smith WW; Schima W; Saini S; Slater GJ; McFarland EG
    AJR Am J Roentgenol; 1998 Mar; 170(3):649-52. PubMed ID: 9490946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MnDPDP for MR imaging of the liver. Results of an independent image evaluation of the European phase III studies.
    Rummeny EJ; Torres CG; Kurdziel JC; Nilsen G; Op de Beeck B; Lundby B
    Acta Radiol; 1997 Jul; 38(4 Pt 2):638-42. PubMed ID: 9245957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI with mangafodipir trisodium in the detection and staging of pancreatic cancer.
    Romijn MG; Stoker J; van Eijck CH; van Muiswinkel JM; Torres CG; Laméris JS
    J Magn Reson Imaging; 2000 Aug; 12(2):261-8. PubMed ID: 10931589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The value of MnDPDP enhancement during MR guided laser interstitial thermoablation of liver tumors.
    Joarder R; de Jode M; Lamb GA; Gedroyc WM
    J Magn Reson Imaging; 2001 Jan; 13(1):37-41. PubMed ID: 11169801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign and malignant hepatocellular tumors: evaluation of tumoral enhancement after mangafodipir trisodium injection on MR imaging.
    Coffin CM; Diche T; Mahfouz A; Alexandre M; Caseiro-Alves F; Rahmouni A; Vasile N; Mathieu D
    Eur Radiol; 1999; 9(3):444-9. PubMed ID: 10087113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: MR imaging with mangafodipir trisodium (Mn-DPDP).
    Murakami T; Baron RL; Peterson MS; Oliver JH; Davis PL; Confer SR; Federle MP
    Radiology; 1996 Jul; 200(1):69-77. PubMed ID: 8657947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sequence optimization in mangafodipir trisodium-enhanced liver and pancreas MRI.
    Wang C; Johansson L; Western A; Fagertun H; Ahlström H
    J Magn Reson Imaging; 1999 Feb; 9(2):280-4. PubMed ID: 10077025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective study of 11 patients.
    Vitellas KM; El-Dieb A; Vaswani KK; Bennett WF; Fromkes J; Ellison C; Bova JG
    AJR Am J Roentgenol; 2002 Aug; 179(2):409-16. PubMed ID: 12130442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of mangafodipir trisodium (MnDPDP) injection for hepatic MRI in adults: results of the U.S. Multicenter phase III clinical trials. Efficacy of early imaging.
    Federle M; Chezmar J; Rubin DL; Weinreb J; Freeny P; Schmiedl UP; Brown JJ; Borrello JA; Lee JK; Semelka RC; Mattrey R; Dachman AH; Saini S; Harms SE; Mitchell DG; Anderson MW; Halford HH; Bennett WF; Young SW; Rifkin M; Gay SB; Ballerini R; Sherwin PF; Robison RO
    J Magn Reson Imaging; 2000 Nov; 12(5):689-701. PubMed ID: 11050638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mangafodipir trisodium-enhanced MRI of hepatocellular carcinoma: correlation with histological characteristics.
    Kim JH; Kim MJ; Park YN; Lee JT; Kim BR; Chung JB; Choi JS; Kim KS; Kim KW
    Clin Radiol; 2008 Nov; 63(11):1195-204. PubMed ID: 18929037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability and utility of mangafodipir trisodium injection (MnDPDP) at the dose of 5 mumol/kg body weight in detecting focal liver tumors: results of a phase III trial using an infusion technique.
    Padovani B; Lecesne R; Raffaelli C; Chevallier P; Drouillard J; Bruneton JN; Lambrechts M; Gordon P
    Eur J Radiol; 1996 Nov; 23(3):205-11. PubMed ID: 9003926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.